Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Dec 02, 2024 9:56am
33 Views
Post# 36340567

RE:RE:RE:RE:Heading to RSNA 2024? Us2.ai ? Ascend Cardiovascular ?

RE:RE:RE:RE:Heading to RSNA 2024? Us2.ai ? Ascend Cardiovascular ?Has anyone seen Bart at RSNA in Chicago? (Bart Hendriks thank you Bart-hope to catch up at RSNA.)
I’m thankful for my family, faith and my colleagues.

I’ll be honest; I’m new and there’s some trepidation in doing the RIGHT for my founder physicians and LPs in a very hostile healthcare environment.

Just know that I’ll go to combat for you and your vision. Always.

Come join us in Chicago if you’re going to hashtagRSNA24 hashtagamazing

Paul Slosar, MD, MHCDS
Dutch Rojas
We are thrilled to introduce Giovanni Lorenz, DO as Partner in PhyCap Fund.

Dr.
Giovanni L. is a Cardiothoracic Radiologist at Glasshaus Imaging. With over 18 years of military service, he has experience in space logistics, fuels operation, family medicine, and as a flight surgeon. Dr. Lorenz is board-certified in two specialties and has logged over 67 combat fly hours.

Dr. Lorenz currently serves as CEO of a cardiovascular imaging center in Lake Oswego, OR while maintaining privileging as a cardiac imager specialist for several academic and large network imaging centers across the US. Dr. Lorenz has been involved in research on advanced cardiac imaging and directed energy, AI integration within cardiac MRI.

Dr. Lorenz's deep expertise in imaging and leadership experience will be an invaluable asset to our team.
 
 
 
 

 

 
Ajouter un commentaire…
 
 

<< Previous
Bullboard Posts
Next >>